TREATMENT OPTIONS FOR PATIENTS WITH CEREBROASTHENIC SYNDROME AFTER COVID-19 INFECTION

Шодиев У.Д

Журнал неврологии и нейрохирургических исследований / Journal of Neurology and Neurosurgical Research · 2022-yil

Annotatsiya

Cerebroasthenic syndrome is a specific pathological condition of the body, which can manifest as the main symptoms-increased chronic fatigue and the development of a psycho-organic syndrome. In addition to fatigue, dizziness, memory impairment, Asthenic Syndrome and prolonged headaches are often characteristic symptoms of this condition. Is the treatment of COVID-19 linked to neurological symptoms? If a patient has a neurological disease, lung, heart, liver, kidney (on dialysis) require special attention, is overweight or is taking immunosuppressants, they may have a higher risk of developing COVID-19. In this article, the main therapeutic measures are aimed at controlling somatic symptoms.

Maqola ma’lumotlari
MualliflarШодиев У.Д
JurnalЖурнал неврологии и нейрохирургических исследований / Journal of Neurology and Neurosurgical Research
Nashr sanasi2022-12-22
Jild3
Son6
TilO‘zbek

Kalit so‘zlar

тяжелый острый респираторный синдром, новый тип коронавируса, сукцинат этилметилгидроксипиридина, полимеразная цепная реакция, severe acute respiratory syndrome, new type of coronavirus, ethylmethylhydroxypyridine succinate, polymerase chain reaction, og'ir o'tkir respirator sindrom, koronavirusning yangi turi, etilmetilgidroksi piridin suksinat, polimeraza zanjiri reaksiyasi

Ilmiy soha

Журнал неврологии и нейрохирургических исследований / Journal of Neurology and Neurosurgical Research jurnalidan boshqa maqolalar

Журнал неврологии и нейрохирургических исследований / Journal of Neurology and Neurosurgical Research — barcha maqolalar